All news

© Getty Images

Neuraxpharm launches new multiple sclerosis treatment in Europe

By Isabel Cameron

Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the first launch of BRIUMVI (ublituximab) in Europe for the treatment of adult patients with relapsing multiple...

© Getty Images

Positive pre-IND meeting with FDA for new ovarian cancer cell therapy

By Isabel Cameron

Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, has completed a pre-investigational new drug (pre-IND) meeting with the FDA for a phase 1/2 clinical trial of its cell therapy product, CTH-401 for the treatment...

© Getty Images

AbbVie receives greenlight from NICE for blood cancer treatment

By Isabel Cameron

AbbVie has announced that the National Institute for Health and Care Excellence (NICE) has recommended epcoritamab (tepkinly), its treatment for adults with diffuse large B-cell lymphoma (DLBCL), an aggressive and fast-growing blood cancer, whose cancer...

Follow us

Webinars